{
  "ptid_time": "016_S_0769_2007-08-20",
  "img_path": "/data/qiuhui/data/adni/images/016_S_0769/2007-08-20/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 100,365 mm³, 234.3% above the reference mean. With a Z-score of 5.57 (100.0th percentile), this represents profound enlargement; hippocampal volume measures 5,756 mm³, 28.3% below the reference mean. With a Z-score of -2.83 (0.2th percentile), this represents significant atrophy; whole brain volume measures 1,151,680 mm³, 1.5% above the reference mean. With a Z-score of 0.21 (58.5th percentile), this represents normal volume ; entorhinal cortex volume measures 2,607 mm³, 38.8% below the reference mean. With a Z-score of -2.69 (0.4th percentile), this represents significant atrophy; fusiform gyrus volume measures 18,711 mm³, 6.0% below the reference mean. With a Z-score of -0.50 (30.8th percentile), this represents normal volume ; middle temporal gyrus volume measures 20,728 mm³, 7.5% below the reference mean. With a Z-score of -0.62 (26.8th percentile), this represents normal volume . ",
  "text_data": "Age is 63.2 years. Gender is Male. Education: 18 years. MMSE: 28.0. Logical Memory: 7.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 544.10 pg/mL (mild reduced); Total tau: 145.20 pg/mL (mild reduced); Phosphorylated tau: 10.97 pg/mL (mild reduced). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement and significant atrophy in the hippocampus and entorhinal cortex—key biomarkers for Alzheimer's disease (AD). However, cognitive performance (MMSE 28) is intact, and CSF biomarkers (Aβ, T-tau, P-tau) are only mildly reduced, not strongly indicative of AD pathology.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely prodromal AD given structural changes but preserved cognition).  \n**Confidence:** **Medium** (structural changes are severe, but biomarker and cognitive data don't fully align with dementia).  \n\n*Note: Close clinical monitoring is recommended due to the mismatch between structural atrophy and mild biomarker/cognitive findings. Progression to dementia is likely but not yet diagnosable.*",
  "timestamp": "2025-07-26T00:07:35.579326"
}